Brenton et al., Carey et al., and Neguyen et al. reported that the pattern of recurrence, whether local or distant, can differ according to the BC subtypes (ER, PR, and HER-2/neu) in patients who receive breast-conserving treatment (BCT). Here, ESR1 is linked to breast cancer.